Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Neose Tech., Inc

Article Abstract:

A comparative analysis of the company sales and financial details of Neose Technologies, Inc. from 1996 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
HEALTH SERVICES, Health care industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Solutia, Inc

Article Abstract:

Solutia Inc.'s sale of a resins and additives business enabled it to meet most of its 2003 financial obligations, but more remain to be paid. There is also pending the PCB litigation that gives the issue unfavorable ranking so investors are advised to look elsewhere.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Chemical industry, Solutia Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Neose Technologies Inc

Article Abstract:

Neose Technologies Inc. has strengthened its financial position and identified its first drug development project. Its stock is suitabe only for venturesome investors.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
NTEC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Securities, Company sales and earnings, Company earnings/profit, Company securities, Neose Technologies Inc., Finance, Company investment, Investments, Statistics, Company business forecast/projection, Company forecasts
Similar abstracts:
  • Abstracts: Genentech, Inc. Genentech Inc
  • Abstracts: ISIS Pharm., Inc. Vertex Pharmaceuticals Inc
  • Abstracts: NPS Pharm., Inc. Pharma Product Development Inc
  • Abstracts: Directly measuring early exercise premiums using American and European S&P 500 Index options
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.